Innovent Biologics, Inc. (HKG:1801)
76.15
+1.30 (1.74%)
Jun 18, 2026, 4:08 PM HKT
Innovent Biologics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst CICC No rating | CICC | Buy Maintains $118.30 | Buy | Maintains | $118.30 | +55.35% | Jun 4, 2026 |
Unknown Analyst BOCOM International Holdings Company No rating | BOCOM International Holdings Company | Buy Maintains $105.00 | Buy | Maintains | $105.00 | +37.89% | Jun 4, 2026 |
Unknown Analyst CSC Financial No rating | CSC Financial | Buy Maintains $147.70 | Buy | Maintains | $147.70 | +93.96% | Jun 3, 2026 |
Unknown Analyst Morgan Stanley No rating | Morgan Stanley | Buy Maintains $135.00 | Buy | Maintains | $135.00 | +77.28% | Jun 2, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Maintains $124.00 | Buy | Maintains | $124.00 | +62.84% | Jun 1, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $111.00 → $113.00 | Buy | Maintains | $111.00 → $113.00 | +48.39% | May 1, 2026 |
Unknown Analyst Shenwan Hongyuan No rating | Shenwan Hongyuan | Buy Maintains $118.20 | Buy | Maintains | $118.20 | +55.22% | Apr 15, 2026 |
Unknown Analyst Zhongtai Securities No rating | Zhongtai Securities | Buy Maintains $136.00 → $146.50 | Buy | Maintains | $136.00 → $146.50 | +92.38% | Apr 10, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.